Global Anti-angiogenic Agent Market Research Report 2016

November 2016 | 109 pages | ID: G036D8438BCEN
QYResearch

Abstracts

Notes:

Production, means the output of Anti-angiogenic Agent

Revenue, means the sales value of Anti-angiogenic Agent

This report studies Anti-angiogenic Agent in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Pfizer, Inc. (US)
• Eli Lilly and Company (USA)
• Bayer HealthCare Pharmaceuticals, Inc. (USA)
• Abbott Laboratories (USA)
• AstraZeneca Plc. (UK)
• Meditrina Pharmaceuticals, Inc. (US)
• Neurocrine Biosciences, Inc. (US)
• AEterna Zentaris, Inc. (Canada)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Anti-angiogenic Agent in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Anti-angiogenic Agent in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Anti-angiogenic Agent Market Research Report 2016

1 ANTI-ANGIOGENIC AGENT MARKET OVERVIEW

1.1 Product Overview and Scope of Anti-angiogenic Agent
1.2 Anti-angiogenic Agent Segment by Type
  1.2.1 Global Production Market Share of Anti-angiogenic Agent by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Anti-angiogenic Agent Segment by Application
  1.3.1 Anti-angiogenic Agent Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Anti-angiogenic Agent Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Anti-angiogenic Agent (2011-2021)

2 GLOBAL ANTI-ANGIOGENIC AGENT MARKET COMPETITION BY MANUFACTURERS

2.1 Global Anti-angiogenic Agent Production and Share by Manufacturers (2015 and 2016)
2.2 Global Anti-angiogenic Agent Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Anti-angiogenic Agent Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti-angiogenic Agent Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-angiogenic Agent Market Competitive Situation and Trends
  2.5.1 Anti-angiogenic Agent Market Concentration Rate
  2.5.2 Anti-angiogenic Agent Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANTI-ANGIOGENIC AGENT PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Anti-angiogenic Agent Production and Market Share by Region (2011-2016)
3.2 Global Anti-angiogenic Agent Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ANTI-ANGIOGENIC AGENT SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Anti-angiogenic Agent Consumption by Regions (2011-2016)
4.2 North America Anti-angiogenic Agent Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Anti-angiogenic Agent Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Anti-angiogenic Agent Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Anti-angiogenic Agent Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Anti-angiogenic Agent Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Anti-angiogenic Agent Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ANTI-ANGIOGENIC AGENT PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Anti-angiogenic Agent Production and Market Share by Type (2011-2016)
5.2 Global Anti-angiogenic Agent Revenue and Market Share by Type (2011-2016)
5.3 Global Anti-angiogenic Agent Price by Type (2011-2016)
5.4 Global Anti-angiogenic Agent Production Growth by Type (2011-2016)

6 GLOBAL ANTI-ANGIOGENIC AGENT MARKET ANALYSIS BY APPLICATION

6.1 Global Anti-angiogenic Agent Consumption and Market Share by Application (2011-2016)
6.2 Global Anti-angiogenic Agent Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANTI-ANGIOGENIC AGENT MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer, Inc. (US)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer, Inc. (US) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly and Company (USA)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Eli Lilly and Company (USA) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Bayer HealthCare Pharmaceuticals, Inc. (USA)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories (USA)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Abbott Laboratories (USA) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca Plc. (UK)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AstraZeneca Plc. (UK) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Meditrina Pharmaceuticals, Inc. (US)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Neurocrine Biosciences, Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 AEterna Zentaris, Inc. (Canada)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Anti-angiogenic Agent Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview

8 ANTI-ANGIOGENIC AGENT MANUFACTURING COST ANALYSIS

8.1 Anti-angiogenic Agent Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-angiogenic Agent

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Anti-angiogenic Agent Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-angiogenic Agent Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTI-ANGIOGENIC AGENT MARKET FORECAST (2016-2021)

12.1 Global Anti-angiogenic Agent Production, Revenue Forecast (2016-2021)
12.2 Global Anti-angiogenic Agent Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Anti-angiogenic Agent Production Forecast by Type (2016-2021)
12.4 Global Anti-angiogenic Agent Consumption Forecast by Application (2016-2021)
12.5 Anti-angiogenic Agent Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-angiogenic Agent
Figure Global Production Market Share of Anti-angiogenic Agent by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Anti-angiogenic Agent Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Anti-angiogenic Agent Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Anti-angiogenic Agent Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Anti-angiogenic Agent Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Anti-angiogenic Agent Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Anti-angiogenic Agent Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Anti-angiogenic Agent Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Anti-angiogenic Agent Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Anti-angiogenic Agent Production of Key Manufacturers (2015 and 2016)
Table Global Anti-angiogenic Agent Production Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-angiogenic Agent Production Share by Manufacturers
Figure 2016 Anti-angiogenic Agent Production Share by Manufacturers
Table Global Anti-angiogenic Agent Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Anti-angiogenic Agent Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Anti-angiogenic Agent Revenue Share by Manufacturers
Table 2016 Global Anti-angiogenic Agent Revenue Share by Manufacturers
Table Global Market Anti-angiogenic Agent Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Anti-angiogenic Agent Average Price of Key Manufacturers in 2015
Table Manufacturers Anti-angiogenic Agent Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti-angiogenic Agent Product Type
Figure Anti-angiogenic Agent Market Share of Top 3 Manufacturers
Figure Anti-angiogenic Agent Market Share of Top 5 Manufacturers
Table Global Anti-angiogenic Agent Production by Regions (2011-2016)
Figure Global Anti-angiogenic Agent Production and Market Share by Regions (2011-2016)
Figure Global Anti-angiogenic Agent Production Market Share by Regions (2011-2016)
Figure 2015 Global Anti-angiogenic Agent Production Market Share by Regions
Table Global Anti-angiogenic Agent Revenue by Regions (2011-2016)
Table Global Anti-angiogenic Agent Revenue Market Share by Regions (2011-2016)
Table 2015 Global Anti-angiogenic Agent Revenue Market Share by Regions
Table Global Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table China Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table India Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Anti-angiogenic Agent Consumption Market by Regions (2011-2016)
Table Global Anti-angiogenic Agent Consumption Market Share by Regions (2011-2016)
Figure Global Anti-angiogenic Agent Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Anti-angiogenic Agent Consumption Market Share by Regions
Table North America Anti-angiogenic Agent Production, Consumption, Import & Export (2011-2016)
Table Europe Anti-angiogenic Agent Production, Consumption, Import & Export (2011-2016)
Table China Anti-angiogenic Agent Production, Consumption, Import & Export (2011-2016)
Table Japan Anti-angiogenic Agent Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Anti-angiogenic Agent Production, Consumption, Import & Export (2011-2016)
Table India Anti-angiogenic Agent Production, Consumption, Import & Export (2011-2016)
Table Global Anti-angiogenic Agent Production by Type (2011-2016)
Table Global Anti-angiogenic Agent Production Share by Type (2011-2016)
Figure Production Market Share of Anti-angiogenic Agent by Type (2011-2016)
Figure 2015 Production Market Share of Anti-angiogenic Agent by Type
Table Global Anti-angiogenic Agent Revenue by Type (2011-2016)
Table Global Anti-angiogenic Agent Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Anti-angiogenic Agent by Type (2011-2016)
Figure 2015 Revenue Market Share of Anti-angiogenic Agent by Type
Table Global Anti-angiogenic Agent Price by Type (2011-2016)
Figure Global Anti-angiogenic Agent Production Growth by Type (2011-2016)
Table Global Anti-angiogenic Agent Consumption by Application (2011-2016)
Table Global Anti-angiogenic Agent Consumption Market Share by Application (2011-2016)
Figure Global Anti-angiogenic Agent Consumption Market Share by Application in 2015
Table Global Anti-angiogenic Agent Consumption Growth Rate by Application (2011-2016)
Figure Global Anti-angiogenic Agent Consumption Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. (US) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Anti-angiogenic Agent Market Share (2011-2016)
Table Eli Lilly and Company (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company (USA) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (USA) Anti-angiogenic Agent Market Share (2011-2016)
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer HealthCare Pharmaceuticals, Inc. (USA) Anti-angiogenic Agent Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories (USA) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Anti-angiogenic Agent Market Share (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Plc. (UK) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Plc. (UK) Anti-angiogenic Agent Market Share (2011-2016)
Table Meditrina Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure Meditrina Pharmaceuticals, Inc. (US) Anti-angiogenic Agent Market Share (2011-2016)
Table Neurocrine Biosciences, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure Neurocrine Biosciences, Inc. (US) Anti-angiogenic Agent Market Share (2011-2016)
Table AEterna Zentaris, Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Production, Revenue, Price and Gross Margin (2011-2016)
Figure AEterna Zentaris, Inc. (Canada) Anti-angiogenic Agent Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-angiogenic Agent
Figure Manufacturing Process Analysis of Anti-angiogenic Agent
Figure Anti-angiogenic Agent Industrial Chain Analysis
Table Raw Materials Sources of Anti-angiogenic Agent Major Manufacturers in 2015
Table Major Buyers of Anti-angiogenic Agent
Table Distributors/Traders List
Figure Global Anti-angiogenic Agent Production and Growth Rate Forecast (2016-2021)
Figure Global Anti-angiogenic Agent Revenue and Growth Rate Forecast (2016-2021)
Table Global Anti-angiogenic Agent Production Forecast by Regions (2016-2021)
Table Global Anti-angiogenic Agent Consumption Forecast by Regions (2016-2021)
Table Global Anti-angiogenic Agent Production Forecast by Type (2016-2021)
Table Global Anti-angiogenic Agent Consumption Forecast by Application (2016-2021)